The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Outcomes of de novo del(17p) in multiple myeloma.
 
Sakthi Kumar
No Relationships to Disclose
 
Nisha Joseph
Honoraria - BMS; Janssen Oncology; Legend Biotech
Consulting or Advisory Role - BMS; GlaxoSmithKline; Janssen Biotech
Research Funding - Bristol Myers Squibb Foundation; Janssen Biotech; Novartis; Regeneron
 
Nishi Shah
No Relationships to Disclose
 
Manali Rupji
No Relationships to Disclose
 
David Jaye
No Relationships to Disclose
 
Vikas Gupta
No Relationships to Disclose
 
Craig Hofmeister
Honoraria - Abbvie; Janssen Oncology
Consulting or Advisory Role - Karyopharm Therapeutics
Research Funding - Abbvie (Inst); Bristol-Myers Squibb (Inst); Menarini Silicon Biosystems (Inst); Pfizer (Inst); Sanofi (Inst)
 
Jonathan Kaufman
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb/Celgene; Incyte; Sanofi; Sebia
Research Funding - Abbvie/Genentech (Inst); Amgen (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); GlaxoSmithKline (Inst); Heidelberg Pharma (Inst); Janssen (Inst); Novartis (Inst); Sutro Biopharma (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Sanofi
 
Sagar Lonial
Stock and Other Ownership Interests - TG Therapeutics
Consulting or Advisory Role - Abbvie; Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen Oncology; Merck; Novartis; Pfizer; Regeneron; Sanofi; Takeda
Research Funding - Bristol-Myers Squibb; Celgene; Janssen Oncology; Novartis; Takeda
Other Relationship - TG Therapeutics
 
Ajay Nooka
Honoraria - AstraZeneca; Blue Earth Diagnostics; Cellectar; Genzyme; GlaxoSmithKline; Janssen Oncology; Kite, a Gilead company; ONK Therapeutics; Opna Bio; Perceptive Informatics; Pfizer; Premier Research; Sebia
Consulting or Advisory Role - AstraZeneca; Blue Earth Diagnostics; Cellectar; Genzyme; GlaxoSmithKline; Janssen Oncology; Kite, a Gilead company; ONK Therapeutics; Opna Bio; Perceptive Informatics; Pfizer; Premier Research; Sebia
Research Funding - Amgen (Inst); Arch Oncology (Inst); Bristol-Myers Squibb/Celgene (Inst); Cellectar (Inst); GlaxoSmithKline (Inst); Janssen Oncology (Inst); Opna Bio (Inst); Pfizer (Inst); Skyline Diagnostics (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - GlaxoSmithKline
 
Richa Parikh
No Relationships to Disclose